Richard Close
Stock Analyst at Canaccord Genuity
(1.26)
# 3,708
Out of 5,109 analysts
150
Total ratings
33.33%
Success rate
-11.64%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSTM HealthStream | Maintains: Hold | $28 | $23.86 | +17.38% | 9 | Dec 17, 2025 | |
| QIPT Quipt Home Medical | Maintains: Hold | $2.3 → $3.65 | $3.53 | +3.40% | 6 | Dec 17, 2025 | |
| PHR Phreesia | Maintains: Buy | $38 → $33 | $16.81 | +96.31% | 12 | Dec 9, 2025 | |
| PGNY Progyny | Maintains: Hold | $23 → $26 | $25.51 | +1.92% | 9 | Nov 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $16 → $9 | $4.13 | +117.92% | 13 | Nov 14, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $32 → $34 | $23.69 | +43.52% | 9 | Nov 12, 2025 | |
| DCGO DocGo | Maintains: Hold | $1.6 → $1.5 | $0.92 | +63.81% | 8 | Nov 12, 2025 | |
| DOCS Doximity | Maintains: Hold | $67 → $58 | $43.78 | +32.48% | 13 | Nov 10, 2025 | |
| CLOV Clover Health Investments | Maintains: Buy | $4.1 → $3.7 | $2.53 | +46.25% | 5 | Nov 6, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $14 → $15 | $10.24 | +46.48% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $65 | $48.20 | +34.85% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $3.65 | +64.38% | 2 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $54 | $33.01 | +63.59% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.38 | +110.08% | 9 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $15.92 | +75.88% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $7.25 | +65.52% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $7.09 | +12.83% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $126.79 | -4.57% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $32.35 | -25.81% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $86.94 | +9.27% | 9 | Apr 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $19 → $18 | $27.11 | -34.53% | 4 | Dec 20, 2018 |
HealthStream
Dec 17, 2025
Maintains: Hold
Price Target: $28
Current: $23.86
Upside: +17.38%
Quipt Home Medical
Dec 17, 2025
Maintains: Hold
Price Target: $2.3 → $3.65
Current: $3.53
Upside: +3.40%
Phreesia
Dec 9, 2025
Maintains: Buy
Price Target: $38 → $33
Current: $16.81
Upside: +96.31%
Progyny
Nov 17, 2025
Maintains: Hold
Price Target: $23 → $26
Current: $25.51
Upside: +1.92%
Evolent Health
Nov 14, 2025
Maintains: Buy
Price Target: $16 → $9
Current: $4.13
Upside: +117.92%
Privia Health Group
Nov 12, 2025
Maintains: Buy
Price Target: $32 → $34
Current: $23.69
Upside: +43.52%
DocGo
Nov 12, 2025
Maintains: Hold
Price Target: $1.6 → $1.5
Current: $0.92
Upside: +63.81%
Doximity
Nov 10, 2025
Maintains: Hold
Price Target: $67 → $58
Current: $43.78
Upside: +32.48%
Clover Health Investments
Nov 6, 2025
Maintains: Buy
Price Target: $4.1 → $3.7
Current: $2.53
Upside: +46.25%
AdaptHealth
Nov 6, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $10.24
Upside: +46.48%
Nov 5, 2025
Maintains: Buy
Price Target: $61 → $65
Current: $48.20
Upside: +34.85%
Oct 31, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $3.65
Upside: +64.38%
Oct 30, 2025
Maintains: Buy
Price Target: $53 → $54
Current: $33.01
Upside: +63.59%
Aug 29, 2025
Maintains: Buy
Price Target: $9 → $5
Current: $2.38
Upside: +110.08%
Aug 8, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $15.92
Upside: +75.88%
May 1, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $7.25
Upside: +65.52%
Apr 3, 2025
Initiates: Buy
Price Target: $8
Current: $7.09
Upside: +12.83%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $126.79
Upside: -4.57%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $32.35
Upside: -25.81%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $86.94
Upside: +9.27%
Dec 20, 2018
Downgrades: Hold
Price Target: $19 → $18
Current: $27.11
Upside: -34.53%